Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies
M Vargas-Soria, M García-Alloza… - Journal of …, 2023 - Springer
Diabetes mellitus is a heterogeneous chronic metabolic disorder characterized by the
presence of hyperglycemia, commonly preceded by a prediabetic state. The excess of blood …
presence of hyperglycemia, commonly preceded by a prediabetic state. The excess of blood …
Development of novel therapeutics targeting the blood–brain barrier: from barrier to carrier
The blood–brain barrier (BBB) is a highly specialized neurovascular unit, initially described
as an intact barrier to prevent toxins, pathogens, and potentially harmful substances from …
as an intact barrier to prevent toxins, pathogens, and potentially harmful substances from …
Diabetic retinopathy: Involved cells, biomarkers, and treatments
J Ren, S Zhang, Y Pan, M **, J Li, Y Luo… - Frontiers in …, 2022 - frontiersin.org
Diabetic retinopathy (DR), a leading cause of vision loss and blindness worldwide, is
caused by retinal neurovascular unit dysfunction, and its cellular pathology involves at least …
caused by retinal neurovascular unit dysfunction, and its cellular pathology involves at least …
[HTML][HTML] Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo
J Fan, W Shen, SR Lee, AE Mathai, R Zhang, G Xu… - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract Rationale: The Notch and transforming growth factor-β (TGFβ) signaling pathways
are two intracellular mechanisms that control fibrosis in general but whether they play a …
are two intracellular mechanisms that control fibrosis in general but whether they play a …
Ginsenoside Rd ameliorates high glucose-induced retinal endothelial injury through AMPK-STRT1 interdependence
K Tang, W Qin, R Wei, Y Jiang, L Fan, Z Wang… - Pharmacological …, 2022 - Elsevier
Diabetic retinopathy (DR) manifests as a complicated and blinding complication in diabetes
mellitus. First-line treatments for advanced DR have shown ocular side-effects in some …
mellitus. First-line treatments for advanced DR have shown ocular side-effects in some …
Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy
X Fu, S Feng, H Qin, L Yan, C Zheng… - Frontiers in Molecular …, 2023 - frontiersin.org
Microglia are the primary resident retinal macrophages that monitor neuronal activity in real-
time and facilitate angiogenesis during retinal development. In certain retinal diseases, the …
time and facilitate angiogenesis during retinal development. In certain retinal diseases, the …
Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti …
W Zheng, C Qian, Y Tang, C Yang, Y Zhou… - Frontiers in …, 2022 - frontiersin.org
Immunotherapy has been recognized as an effective and important therapeutic modality for
multiple types of cancer. Nevertheless, it has been increasing recognized that clinical …
multiple types of cancer. Nevertheless, it has been increasing recognized that clinical …
Pericytes in Alzheimer's disease: Key players and therapeutic targets
Y Zhang, BR Mu, Z Ran, T Zhu, X Huang, X Yang… - Experimental …, 2024 - Elsevier
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that leads to
progressive cognitive decline and neuropathological changes. Pericytes, which are vessel …
progressive cognitive decline and neuropathological changes. Pericytes, which are vessel …
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease
R Tarawneh, RS Kasper, J Sanford… - Annals of clinical …, 2022 - Wiley Online Library
Objective Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease
(AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a …
(AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a …
miR-155 in the resolution of atherosclerosis
R Bruen, S Fitzsimons, O Belton - Frontiers in pharmacology, 2019 - frontiersin.org
Atherosclerosis is a chronic progressive inflammatory disease where advanced lesions can
eventually completely obstruct blood flow resulting in clinical events, such as a myocardial …
eventually completely obstruct blood flow resulting in clinical events, such as a myocardial …